fda approves semaglutide The approved a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 FDA Approves Higher-Dose Wegovy To

This approach often involves detailed testing to uncover underlying dysfunctions, like nutrient deficiencies or hormonal shifts, and tailors interventions to restore the body's natural equilibrium

For patients with severe or persistent GI symptoms, temporary dose reduction or holding the GLP-1 medication (under clinician guidance) may be considered

This transition could be bittersweet

Weight loss as a result of GLP-1s, when medically appropriate, can result in health benefits like lower blood pressure, a lower risk of developing type 2 diabetes, improved sleep and, in some cases, an overall improved quality of life

Phil Cowley: Registered Pharmacist The essential nature of our bodies is they want us to be healthy

Lean Turkey & Herbs If you prefer a lighter, brighter flavor, ground turkey pairs beautifully with fresh basil or a squeeze of lemon